Chroma Medicine
Glen H.G. Acosta is an accomplished scientist with extensive experience in preclinical pharmacology and research management. Currently serving as Senior Scientist at Chroma Medicine, Glen oversees Preclinical In Vivo Pharmacology and the Animal Care Facility. Prior roles include Senior Scientist at Leal Therapeutics, where responsibilities encompassed project leadership in CNS preclinical research, and Scientist II at Dicerna Pharmaceuticals, where Glen directed collaborations and pharmacological studies for novel RNAi therapeutics. Glen's previous experience includes significant roles at The Jackson Laboratory and Purdue University, contributing to important research in neurodegeneration and animal care protocols. Glen holds a Doctor of Philosophy in Neuroscience from Purdue University, as well as a Master of Science and Bachelor of Science from the University of North Carolina at Greensboro.
Chroma Medicine
1 followers
Chroma Medicine is pioneering a new class of genomic medicines that harness epigenetics, nature’s innate mechanism for gene regulation, revolutionizing the treatment of genetically driven diseases.